Serpiginous choroiditis

Common Name(s)

Serpiginous choroiditis

Serpiginous choroiditis is a rare inflammatory eye condition that typically develops between age 30 and 70 years. Affected individuals have lesions in the eye that last from weeks to months and involve scarring of the eye tissue.  Recurrence of these lesions is common in serpiginous choroiditis. Vision loss may occur in one or both eyes when the macula is involved. Treatment options involve anti-inflammatory and immune-suppressing medications.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Serpiginous choroiditis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Serpiginous choroiditis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Serpiginous choroiditis" returned 18 free, full-text research articles on human participants. First 3 results:

Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis.
 

Author(s): Avirupa Ghose, Promod S Bhende, Jyotirmoy Biswas

Journal: Indian J Ophthalmol. 2016 Sep;64(9):681-682.

 

Active serpiginous choroiditis (SC) is a vision-threatening condition which requires intensive treatment using corticosteroids and/or immunosuppressives, especially if the lesions are involving or encroaching on the macula. Use of oral and intravenous high-dose steroids are contraindicated ...

Last Updated: 17 Nov 2016

Go To URL
[A form of macular serpiginous choroiditis].
 

Author(s): C Maurin, M-P Delolme, C Granier, L Kodjikian, F Chiambaretta

Journal: J Fr Ophtalmol. 2016 Apr;39(4):e85-8.

 

Last Updated: 18 Apr 2016

Go To URL
[Macular serpiginous choroiditis].
 

Author(s): Meriem Abdellaoui, Hicham Tahri

Journal:

 

Last Updated: 2 Sep 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Serpiginous choroiditis" returned 2 free, full-text review articles on human participants. First 3 results:

[Serpiginous-like choroiditis and intraocular tuberculosis: report of 2 cases and literature review].
 

Author(s): Hakima Elouarradi, Samira Tachfouti, Lalla Ouafae Cherkaoui, Othmane Charhi, Uchama Daoudi, Saloua Khalil, Nouha Zerkaoui, Amal Alouane, Kamal Naciri, Rajae Daoudi

Journal:

 

Last Updated: 18 Jul 2015

Go To URL
Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis.
 

Author(s): Hossein Nazari Khanamiri, Narsing A Rao

Journal: Surv Ophthalmol. ;58(3):203-32.

 

Serpiginous choroiditis (SC) is a posterior uveitis displaying a geographic pattern of choroiditis, extending from the juxtapapillary choroid and intermittently spreading centrifugally. The choroiditis involves the overlying retinal pigment epithelium, and the outer retina. This intraocular ...

Last Updated: 19 Apr 2013

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.